1. Home
  2. WALD vs CCCC Comparison

WALD vs CCCC Comparison

Compare WALD & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.93

Market Cap

228.8M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WALD
CCCC
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.8M
240.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WALD
CCCC
Price
$1.93
$2.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$4.76
$7.25
AVG Volume (30 Days)
169.5K
1.9M
Earning Date
11-24-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$274,560,000.00
$30,108,000.00
Revenue This Year
$4.61
N/A
Revenue Next Year
$11.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.22
N/A
52 Week Low
$1.48
$1.09
52 Week High
$4.10
$4.26

Technical Indicators

Market Signals
Indicator
WALD
CCCC
Relative Strength Index (RSI) 41.56 34.04
Support Level $1.73 $2.00
Resistance Level $2.01 $2.69
Average True Range (ATR) 0.16 0.18
MACD -0.05 -0.07
Stochastic Oscillator 25.33 3.55

Price Performance

Historical Comparison
WALD
CCCC

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: